naphthalimides has been researched along with Acute Promyelocytic Leukemia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Liang, X; Liu, J; Qian, X; Xu, K; Xu, Y | 1 |
1 other study(ies) available for naphthalimides and Acute Promyelocytic Leukemia
Article | Year |
---|---|
B1, a novel amonafide analogue, overcomes the resistance conferred by Bcl-2 in human promyelocytic leukemia HL60 cells.
Topics: 14-3-3 Proteins; Adenine; Antineoplastic Agents; Apoptosis; Benzothiazoles; Cell Line, Tumor; DNA-Binding Proteins; Down-Regulation; Drug Resistance, Neoplasm; Gene Knockdown Techniques; Genes, bcl-2; Genes, MDR; Genes, p53; HL-60 Cells; Humans; K562 Cells; Leukemia, Promyelocytic, Acute; Naphthalimides; Organophosphonates; Proto-Oncogene Proteins c-bcl-2; RNA, Small Interfering; U937 Cells | 2010 |